General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer Healthcare Pharmaceuticals(MODEST)
CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer Healthcare Pharmaceuticals(MODEST)
© 2024 American College of Cardiology Foundation. All rights reserved.